Biomimetic nanocomplex based corneal neovascularization theranostics
Journal of Controlled Release · 2024-10 · 374 · 50-60
DOI: 10.1016/j.jconrel.2024.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-10. Verfasst von Jinfa Ye und 11 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen University Affiliated Xiamen Eye Center, Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China; Fuji…. Hauptthemen laut MEDLINE: Corneal Neovascularization, Polylactic Acid-Polyglycolic Acid Copolymer, Indocyanine Green, Nanoparticles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Committee, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Corneal neovascularization (CNV) is a major cause of blindness worldwide. However, the recent drug treatment is limited by repeated administration and low drug bioavailability. In this work, SU6668 (an inhibitor of receptor tyrosine kinases) and indocyanine green (ICG) are loaded onto poly(lactic-co-glycolic acid) (PLGA) nanoparticles, and then coated with anti-VEGFR2 single chain antibody (AbVr2 scFv) genetically engineered cell membrane vesicles. The nanomedicine is delivered via eye drops, and the hyperthermia induced by laser irradiation could block the blood vessels. Meanwhile, the photothermal effect can also cause the degradation of nanomaterials and release chemotherapeutic drugs in the blocked area, thereby continuously inhibit the neovascularization. Furthermore, SU6668 could inhibit the expression of heat shock protein 70 (HSP70), promoting the cell death induced by photothermal effect. In conclusion, the combination of photothermal and chemotherapy drugs provides a novel, effective and safe approach for the treatment of CNV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiamen University Affiliated Xiamen Eye Center, Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China; Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fuji…
- Department of Interventional Radiology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, China.
- Department of Pharmacy, Xiamen Medical College, Xiamen 361023, China. Electronic address: cc@xmmc.edu.cn.
- Department of Pharmacy, Xiamen Medical College, Xiamen 361023, China.
- State Key Laboratory of Physical Chemistry of Solid Surfaces & The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361002, China…
Förderung
- Shenzhen Science and Technology Innovation Committee
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Natural Science Foundation of Xiamen Municipality
- Natural Science Foundation of Fujian Province
Zitieren
APA
Ye, J., Cheng, Y., Wen, X., Han, Y., Wei, X., Wu, Y., Chen, C., Su, M., Cai, S., Pan, J., Liu, G., & Chu, C. (2024). Biomimetic nanocomplex based corneal neovascularization theranostics. Journal of Controlled Release, 374, 50-60. https://doi.org/10.1016/j.jconrel.2024.08.002
Vancouver
Ye J, Cheng Y, Wen X, Han Y, Wei X, Wu Y, et al. Biomimetic nanocomplex based corneal neovascularization theranostics. Journal of Controlled Release. 2024;374:50-60. doi:10.1016/j.jconrel.2024.08.002
BibTeX
@article{Ye2024,
author = {Ye, Jinfa and Cheng, Yuhang and Wen, Xiaofei and Han, Yun and Wei, Xingyuan and Wu, Yiming and Chen, Chuan and Su, Min and Cai, Shundong and Pan, Jintao and Liu, Gang and Chu, Chengchao},
title = {Biomimetic nanocomplex based corneal neovascularization theranostics},
journal = {Journal of Controlled Release},
year = {2024},
volume = {374},
pages = {50--60},
doi = {10.1016/j.jconrel.2024.08.002}
}
EUVIMED